Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RELAXaHEAD for Headache Patients (Phase II): RELAXaHEAD for Migraine and Sleep

NCT05466682 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT05466682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05466682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RELAXaHEAD for Headache Patients (Phase II): RELAXaHEAD for Migraine and Sleep
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Completed
Start date
June 9, 2022
Completion date
June 19, 2023
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

headache, insomnia, migraine, multiple sclerosis